Get our free email newsletter

fda

FDA Establishes Device Fees for FY 2019

The U.S. Food and Drug Administration (FDA) has announced user fees applicable to medical...

U.S. FDA Seeking Input on Software Precertification Pilot Program

The U.S. Food and Drug Administration (FDA) is seeking public comment on an updated version of its proposed pilot program to speed the approval of software used in digital health applications.

U.S. FDA Releases Draft Guidance on Humanitarian Device Exemptions

The FDA has published a draft guidance to clarify its requirements and review practices in connection with medical device applications submitted under its Humanitarian Device Exemption (HDE) Program.

FDA Exempts Certain Class II Devices from Premarket Notification

The FDA has issued a Final Order that exempts certain Class II medical devices from the agency’s premarket notification (510(k)) requirements.

FDA Updates List of Recognized Standards

The FDA has published an updated list of recognized consensus standards that can used in support of premarket medical device reviews conducted by the agency.
- From Our Sponsors -

FDA Set to Propose Adoption of ISO 13485 for Quality Systems

In an effort to harmonize its medical device quality management system regulations with globally-accepted...

FDA Issues Draft Guidance on Multiple Function Device Products

The U.S. Food and Drug Administration (FDA) has issued a new draft guidance intended to clarify its policy regarding the assessment of medical devices offering multiple functions.

U.S. FDA Releases Draft Guidance on Demonstrating Substantial Equivalence

The FDA has released a draft guidance that may help reduce the burden on device manufacturers seeking to demonstrate substantial equivalence for some types of new medical devices.

U.S. FDA Issues Draft Guidance on Transfer of Premarket Notification

The FDA has issued a draft Guidance on transferring a premarket notification (510(k)) clearance from one person to another.

FDA Warns Medical Device Manufacturers for Post-Market Surveillance Failures

The U.S. Food and Drug Administration (FDA) has warned the manufacturers of duodenoscopes of their obligation to conduct post-market surveillance studies to assess the effectiveness of post-use decontamination protocols.
- From Our Sponsors -

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.